Cargando…

Feasibility of three times weekly symptom screening in pediatric cancer patients

OBJECTIVE: Primary objective was to determine the feasibility of three times weekly symptom reporting by pediatric cancer patients for eight weeks. METHODS: We included English-speaking patients 8–18 years of age with cancer. Patients were sent reminders by text or email to complete Symptom Screenin...

Descripción completa

Detalles Bibliográficos
Autores principales: Calligan, Maryann, Chakkalackal, Lauren, Dadzie, Grace, Tardif-Theriault, Cassandra, Cook, Sadie, Vettese, Emily, Soman, Dilip, Kuczynski, Susan, Schechter, Tal, Dupuis, L. Lee, Sung, Lillian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809057/
https://www.ncbi.nlm.nih.gov/pubmed/36597030
http://dx.doi.org/10.1186/s12885-022-10400-1
_version_ 1784863053602357248
author Calligan, Maryann
Chakkalackal, Lauren
Dadzie, Grace
Tardif-Theriault, Cassandra
Cook, Sadie
Vettese, Emily
Soman, Dilip
Kuczynski, Susan
Schechter, Tal
Dupuis, L. Lee
Sung, Lillian
author_facet Calligan, Maryann
Chakkalackal, Lauren
Dadzie, Grace
Tardif-Theriault, Cassandra
Cook, Sadie
Vettese, Emily
Soman, Dilip
Kuczynski, Susan
Schechter, Tal
Dupuis, L. Lee
Sung, Lillian
author_sort Calligan, Maryann
collection PubMed
description OBJECTIVE: Primary objective was to determine the feasibility of three times weekly symptom reporting by pediatric cancer patients for eight weeks. METHODS: We included English-speaking patients 8–18 years of age with cancer. Patients were sent reminders by text or email to complete Symptom Screening in Pediatrics Tool (SSPedi) three times weekly for eight weeks. When patients reported at least one severely bothersome symptom, the symptom report was emailed to the primary healthcare team. Patient-reported outcomes were obtained at baseline, week 4 ± 1 and week 8 ± 1. Symptom documentation, intervention provision for symptoms and unplanned healthcare encounters were determined by chart review at weeks 4 and 8. The primary endpoint was feasibility, defined as at least 75% patients achieving adherence with at least 60% of SSPedi evaluations. We planned to enroll successive cohorts until this threshold was met. RESULTS: Two cohorts consisting of 30 patients (cohort 1 (n = 20) and cohort 2 (n = 10)) were required to meet the feasibility threshold. In cohort 1, 11/20 (55%) met the SSPedi completion threshold. Interventions applied after cohort 1 included engaging parents to facilitate pediatric patient self-report, offering mechanisms to remember username and password and highlighting potential benefits of symptom feedback to clinicians. In cohort 2, 9/10 (90%) met the SSPedi completion threshold and thus feasibility was met. Patient-reported outcomes and chart review outcomes were obtained for all participants in cohort 2. CONCLUSIONS: Three times weekly symptom reporting by pediatric patients with cancer for eight weeks was feasible. Mechanisms to enhance three times weekly symptom reporting were identified and implemented. Future studies of longitudinal symptom screening can now be planned. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10400-1.
format Online
Article
Text
id pubmed-9809057
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98090572023-01-04 Feasibility of three times weekly symptom screening in pediatric cancer patients Calligan, Maryann Chakkalackal, Lauren Dadzie, Grace Tardif-Theriault, Cassandra Cook, Sadie Vettese, Emily Soman, Dilip Kuczynski, Susan Schechter, Tal Dupuis, L. Lee Sung, Lillian BMC Cancer Research OBJECTIVE: Primary objective was to determine the feasibility of three times weekly symptom reporting by pediatric cancer patients for eight weeks. METHODS: We included English-speaking patients 8–18 years of age with cancer. Patients were sent reminders by text or email to complete Symptom Screening in Pediatrics Tool (SSPedi) three times weekly for eight weeks. When patients reported at least one severely bothersome symptom, the symptom report was emailed to the primary healthcare team. Patient-reported outcomes were obtained at baseline, week 4 ± 1 and week 8 ± 1. Symptom documentation, intervention provision for symptoms and unplanned healthcare encounters were determined by chart review at weeks 4 and 8. The primary endpoint was feasibility, defined as at least 75% patients achieving adherence with at least 60% of SSPedi evaluations. We planned to enroll successive cohorts until this threshold was met. RESULTS: Two cohorts consisting of 30 patients (cohort 1 (n = 20) and cohort 2 (n = 10)) were required to meet the feasibility threshold. In cohort 1, 11/20 (55%) met the SSPedi completion threshold. Interventions applied after cohort 1 included engaging parents to facilitate pediatric patient self-report, offering mechanisms to remember username and password and highlighting potential benefits of symptom feedback to clinicians. In cohort 2, 9/10 (90%) met the SSPedi completion threshold and thus feasibility was met. Patient-reported outcomes and chart review outcomes were obtained for all participants in cohort 2. CONCLUSIONS: Three times weekly symptom reporting by pediatric patients with cancer for eight weeks was feasible. Mechanisms to enhance three times weekly symptom reporting were identified and implemented. Future studies of longitudinal symptom screening can now be planned. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10400-1. BioMed Central 2023-01-03 /pmc/articles/PMC9809057/ /pubmed/36597030 http://dx.doi.org/10.1186/s12885-022-10400-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Calligan, Maryann
Chakkalackal, Lauren
Dadzie, Grace
Tardif-Theriault, Cassandra
Cook, Sadie
Vettese, Emily
Soman, Dilip
Kuczynski, Susan
Schechter, Tal
Dupuis, L. Lee
Sung, Lillian
Feasibility of three times weekly symptom screening in pediatric cancer patients
title Feasibility of three times weekly symptom screening in pediatric cancer patients
title_full Feasibility of three times weekly symptom screening in pediatric cancer patients
title_fullStr Feasibility of three times weekly symptom screening in pediatric cancer patients
title_full_unstemmed Feasibility of three times weekly symptom screening in pediatric cancer patients
title_short Feasibility of three times weekly symptom screening in pediatric cancer patients
title_sort feasibility of three times weekly symptom screening in pediatric cancer patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809057/
https://www.ncbi.nlm.nih.gov/pubmed/36597030
http://dx.doi.org/10.1186/s12885-022-10400-1
work_keys_str_mv AT calliganmaryann feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients
AT chakkalackallauren feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients
AT dadziegrace feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients
AT tardiftheriaultcassandra feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients
AT cooksadie feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients
AT vetteseemily feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients
AT somandilip feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients
AT kuczynskisusan feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients
AT schechtertal feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients
AT dupuisllee feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients
AT sunglillian feasibilityofthreetimesweeklysymptomscreeninginpediatriccancerpatients